Trial intelligence / Profile preview

Ketofol versus dexmedetomidine versus propofol/isoflurane anesthesia for dilatation and curettage

IRCT20191022045203N1Phase 3Completed

Sponsor
Ardabil University of Medical Sciences
Start
Mar 2018
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of ketamine, propofol, dexmedetomidine and isoflurane (3 arms), sponsored by Ardabil University of Medical Sciences. Primary endpoint: Incidence of apnea during anesthesia. Started Mar 2018; status: completed.

02

Drugs

ketaminepropofoldexmedetomidineisoflurane

Beyond the preview

Go deeper on IRCT20191022045203N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20191022045203N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call